Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-11-10 4:41 pm Sale |
2022-10-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
Select Equity Group, L.P. | 11,521,575 8.800% |
-9,020,928 (-43.91%) |
Filing History |
| 2022-09-06 4:00 pm Unchanged |
2022-09-06 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
MASSACHUSETTS FINANCIAL SERVICES CO | 13,932,684 10.600% |
0 (Unchanged) |
Filing History |
| 2022-09-06 2:37 pm Purchase |
2022-09-06 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
MASSACHUSETTS FINANCIAL SERVICES CO | 13,932,684 10.600% |
5,929,663 (+74.09%) |
Filing History |
| 2022-07-11 08:49 am Sale |
2022-07-08 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
FMR CORP | 4,007,903 3.046% |
-8,699,742 (-68.46%) |
Filing History |
| 2022-02-14 10:11 am Sale |
2021-12-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
D1 Capital Partners L.P. | 0 0.000% |
-5,930,000 (Position Closed) |
Filing History |
| 2022-02-11 5:38 pm Purchase |
2021-12-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
Select Equity Group, L.P. | 20,542,503 15.600% |
5,607,666 (+37.55%) |
Filing History |
| 2022-02-11 4:16 pm Sale |
2021-12-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
MARAVAI LIFE SCIENCES HOLDINGS 2 LLC | 145,350,229 56.970% |
-43,270,415 (-22.94%) |
Filing History |
| 2022-02-10 08:22 am Purchase |
2021-12-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
The Vanguard Group | 10,533,609 8.010% |
5,820,157 (+123.48%) |
Filing History |
| 2022-02-09 09:22 am Purchase |
2022-02-08 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
FMR CORP | 12,707,645 9.666% |
3,004,403 (+30.96%) |
Filing History |
| 2022-02-02 12:46 pm Purchase |
2022-02-02 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
MASSACHUSETTS FINANCIAL SERVICES CO | 8,003,021 6.100% |
8,003,021 (New Position) |
Filing History |
| 2021-11-09 5:07 pm Purchase |
2021-10-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
Select Equity Group, L.P. | 14,934,837 11.400% |
14,934,837 (New Position) |
Filing History |
| 2021-04-12 1:05 pm Purchase |
2021-04-09 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
FMR CORP | 9,703,242 10.039% |
3,996,681 (+70.04%) |
Filing History |
| 2021-02-16 09:39 am Purchase |
2020-12-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
D1 Capital Partners L.P. | 5,930,000 6.100% |
5,930,000 (New Position) |
Filing History |
| 2021-02-11 4:00 pm Purchase |
2020-12-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
MARAVAI LIFE SCIENCES HOLDINGS 2 LLC | 188,620,644 73.200% |
188,620,644 (New Position) |
Filing History |
| 2021-02-10 11:22 am Purchase |
2020-12-31 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
The Vanguard Group | 4,713,452 5.300% |
4,713,452 (New Position) |
Filing History |
| 2021-02-08 10:27 am Purchase |
2021-02-05 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
FMR CORP | 5,706,561 6.414% |
5,706,561 (New Position) |
Filing History |